FCGR3B and COVID-19: The expression of FCGR3B was then validated in another single-cell BALF data set (Grant et al., 2021) in which upregulation of FCGR3B in severe COVID-19 samples as compared with control was again evident (Figure 3D, p < 1.08 × 10−143).